nodes	percent_of_prediction	percent_of_DWPC	metapath
Ifosfamide—germ cell cancer—head and neck cancer	0.693	1	CtDrD
Ifosfamide—CYP2A6—Fluorouracil—head and neck cancer	0.0491	0.277	CbGbCtD
Ifosfamide—CYP3A7-CYP3A51P—Docetaxel—head and neck cancer	0.0256	0.145	CbGbCtD
Ifosfamide—CYP3A7—Docetaxel—head and neck cancer	0.0256	0.145	CbGbCtD
Ifosfamide—CYP2C8—Fluorouracil—head and neck cancer	0.0242	0.137	CbGbCtD
Ifosfamide—CYP3A5—Docetaxel—head and neck cancer	0.0192	0.108	CbGbCtD
Ifosfamide—CYP2C9—Fluorouracil—head and neck cancer	0.0169	0.0953	CbGbCtD
Ifosfamide—CYP3A4—Vinblastine—head and neck cancer	0.0091	0.0513	CbGbCtD
Ifosfamide—CYP3A4—Docetaxel—head and neck cancer	0.0075	0.0423	CbGbCtD
Ifosfamide—Nail disorder—Docetaxel—head and neck cancer	0.000454	0.004	CcSEcCtD
Ifosfamide—Renal failure acute—Hydroxyurea—head and neck cancer	0.000445	0.00393	CcSEcCtD
Ifosfamide—Cyst—Docetaxel—head and neck cancer	0.00044	0.00389	CcSEcCtD
Ifosfamide—Dysarthria—Fluorouracil—head and neck cancer	0.000431	0.0038	CcSEcCtD
Ifosfamide—Neuralgia—Docetaxel—head and neck cancer	0.000424	0.00374	CcSEcCtD
Ifosfamide—Inflammation—Fluorouracil—head and neck cancer	0.00042	0.00371	CcSEcCtD
Ifosfamide—Ileus—Docetaxel—head and neck cancer	0.000416	0.00367	CcSEcCtD
Ifosfamide—Interstitial lung disease—Docetaxel—head and neck cancer	0.000416	0.00367	CcSEcCtD
Ifosfamide—Blood creatinine increased—Hydroxyurea—head and neck cancer	0.000385	0.0034	CcSEcCtD
Ifosfamide—Pleural effusion—Docetaxel—head and neck cancer	0.000384	0.00339	CcSEcCtD
Ifosfamide—Hepatotoxicity—Docetaxel—head and neck cancer	0.000381	0.00336	CcSEcCtD
Ifosfamide—Angina pectoris—Vinblastine—head and neck cancer	0.00038	0.00335	CcSEcCtD
Ifosfamide—Necrosis—Docetaxel—head and neck cancer	0.000375	0.00331	CcSEcCtD
Ifosfamide—Coma—Fluorouracil—head and neck cancer	0.000373	0.00329	CcSEcCtD
Ifosfamide—Breast disorder—Hydroxyurea—head and neck cancer	0.000372	0.00328	CcSEcCtD
Ifosfamide—Pancytopenia—Vinblastine—head and neck cancer	0.00037	0.00327	CcSEcCtD
Ifosfamide—Sepsis—Fluorouracil—head and neck cancer	0.000354	0.00312	CcSEcCtD
Ifosfamide—Pancreatitis—Hydroxyurea—head and neck cancer	0.000348	0.00307	CcSEcCtD
Ifosfamide—Eye irritation—Docetaxel—head and neck cancer	0.000345	0.00304	CcSEcCtD
Ifosfamide—Acute coronary syndrome—Vinblastine—head and neck cancer	0.000343	0.00302	CcSEcCtD
Ifosfamide—Thrombophlebitis—Fluorouracil—head and neck cancer	0.000342	0.00302	CcSEcCtD
Ifosfamide—Myocardial infarction—Vinblastine—head and neck cancer	0.000341	0.00301	CcSEcCtD
Ifosfamide—Neuropathy peripheral—Vinblastine—head and neck cancer	0.000341	0.00301	CcSEcCtD
Ifosfamide—Pancytopenia—Hydroxyurea—head and neck cancer	0.000338	0.00298	CcSEcCtD
Ifosfamide—Extravasation—Docetaxel—head and neck cancer	0.000337	0.00298	CcSEcCtD
Ifosfamide—Swelling—Fluorouracil—head and neck cancer	0.000336	0.00296	CcSEcCtD
Ifosfamide—Amenorrhoea—Docetaxel—head and neck cancer	0.000335	0.00296	CcSEcCtD
Ifosfamide—Dysuria—Hydroxyurea—head and neck cancer	0.000332	0.00293	CcSEcCtD
Ifosfamide—Disorientation—Fluorouracil—head and neck cancer	0.000331	0.00292	CcSEcCtD
Ifosfamide—Agranulocytosis—Vinblastine—head and neck cancer	0.000324	0.00286	CcSEcCtD
Ifosfamide—Drug interaction—Docetaxel—head and neck cancer	0.000317	0.0028	CcSEcCtD
Ifosfamide—Infestation NOS—Hydroxyurea—head and neck cancer	0.000317	0.0028	CcSEcCtD
Ifosfamide—Infestation—Hydroxyurea—head and neck cancer	0.000317	0.0028	CcSEcCtD
Ifosfamide—Amnesia—Fluorouracil—head and neck cancer	0.000315	0.00278	CcSEcCtD
Ifosfamide—Haemoglobin—Vinblastine—head and neck cancer	0.000314	0.00277	CcSEcCtD
Ifosfamide—Haemorrhage—Vinblastine—head and neck cancer	0.000312	0.00275	CcSEcCtD
Ifosfamide—Neuropathy peripheral—Hydroxyurea—head and neck cancer	0.000311	0.00274	CcSEcCtD
Ifosfamide—Hearing impaired—Docetaxel—head and neck cancer	0.000309	0.00273	CcSEcCtD
Ifosfamide—Stomatitis—Hydroxyurea—head and neck cancer	0.000309	0.00273	CcSEcCtD
Ifosfamide—Inflammation—Docetaxel—head and neck cancer	0.000303	0.00268	CcSEcCtD
Ifosfamide—Cardiac failure—Fluorouracil—head and neck cancer	0.000303	0.00268	CcSEcCtD
Ifosfamide—Hepatobiliary disease—Hydroxyurea—head and neck cancer	0.0003	0.00264	CcSEcCtD
Ifosfamide—Respiratory failure—Docetaxel—head and neck cancer	0.0003	0.00264	CcSEcCtD
Ifosfamide—Gastrointestinal haemorrhage—Fluorouracil—head and neck cancer	0.000296	0.00261	CcSEcCtD
Ifosfamide—Osteoarthritis—Fluorouracil—head and neck cancer	0.000296	0.00261	CcSEcCtD
Ifosfamide—Pulmonary embolism—Docetaxel—head and neck cancer	0.000294	0.0026	CcSEcCtD
Ifosfamide—Haemoglobin—Hydroxyurea—head and neck cancer	0.000286	0.00252	CcSEcCtD
Ifosfamide—Haemorrhage—Hydroxyurea—head and neck cancer	0.000285	0.00251	CcSEcCtD
Ifosfamide—Hallucination—Hydroxyurea—head and neck cancer	0.000283	0.0025	CcSEcCtD
Ifosfamide—Colitis—Docetaxel—head and neck cancer	0.000283	0.00249	CcSEcCtD
Ifosfamide—Cardiac arrest—Fluorouracil—head and neck cancer	0.000281	0.00248	CcSEcCtD
Ifosfamide—Skin exfoliation—Docetaxel—head and neck cancer	0.000281	0.00248	CcSEcCtD
Ifosfamide—Alopecia—Vinblastine—head and neck cancer	0.000276	0.00243	CcSEcCtD
Ifosfamide—Neoplasm—Docetaxel—head and neck cancer	0.000266	0.00235	CcSEcCtD
Ifosfamide—Pulmonary oedema—Docetaxel—head and neck cancer	0.000262	0.00231	CcSEcCtD
Ifosfamide—Angiopathy—Hydroxyurea—head and neck cancer	0.000258	0.00228	CcSEcCtD
Ifosfamide—Sepsis—Docetaxel—head and neck cancer	0.000255	0.00225	CcSEcCtD
Ifosfamide—Chills—Hydroxyurea—head and neck cancer	0.000255	0.00225	CcSEcCtD
Ifosfamide—Ill-defined disorder—Vinblastine—head and neck cancer	0.000252	0.00222	CcSEcCtD
Ifosfamide—Alopecia—Hydroxyurea—head and neck cancer	0.000251	0.00222	CcSEcCtD
Ifosfamide—Anaemia—Vinblastine—head and neck cancer	0.000251	0.00221	CcSEcCtD
Ifosfamide—Angina pectoris—Fluorouracil—head and neck cancer	0.000249	0.0022	CcSEcCtD
Ifosfamide—Phlebitis—Docetaxel—head and neck cancer	0.000248	0.00219	CcSEcCtD
Ifosfamide—Erythema—Hydroxyurea—head and neck cancer	0.000248	0.00219	CcSEcCtD
Ifosfamide—Thrombophlebitis—Docetaxel—head and neck cancer	0.000247	0.00218	CcSEcCtD
Ifosfamide—Malaise—Vinblastine—head and neck cancer	0.000245	0.00216	CcSEcCtD
Ifosfamide—Vertigo—Vinblastine—head and neck cancer	0.000244	0.00215	CcSEcCtD
Ifosfamide—Leukopenia—Vinblastine—head and neck cancer	0.000243	0.00214	CcSEcCtD
Ifosfamide—Pancytopenia—Fluorouracil—head and neck cancer	0.000243	0.00214	CcSEcCtD
Ifosfamide—Swelling—Docetaxel—head and neck cancer	0.000242	0.00214	CcSEcCtD
Ifosfamide—Deafness—Docetaxel—head and neck cancer	0.000239	0.00211	CcSEcCtD
Ifosfamide—Hepatic failure—Docetaxel—head and neck cancer	0.000238	0.0021	CcSEcCtD
Ifosfamide—Convulsion—Vinblastine—head and neck cancer	0.000235	0.00208	CcSEcCtD
Ifosfamide—Hypertension—Vinblastine—head and neck cancer	0.000234	0.00207	CcSEcCtD
Ifosfamide—Ill-defined disorder—Hydroxyurea—head and neck cancer	0.00023	0.00203	CcSEcCtD
Ifosfamide—Pneumonia—Fluorouracil—head and neck cancer	0.000229	0.00202	CcSEcCtD
Ifosfamide—Anaemia—Hydroxyurea—head and neck cancer	0.000229	0.00202	CcSEcCtD
Ifosfamide—Discomfort—Vinblastine—head and neck cancer	0.000228	0.00202	CcSEcCtD
Ifosfamide—Infestation—Fluorouracil—head and neck cancer	0.000228	0.00201	CcSEcCtD
Ifosfamide—Infestation NOS—Fluorouracil—head and neck cancer	0.000228	0.00201	CcSEcCtD
Ifosfamide—Atrial fibrillation—Docetaxel—head and neck cancer	0.000225	0.00199	CcSEcCtD
Ifosfamide—Acute coronary syndrome—Fluorouracil—head and neck cancer	0.000225	0.00198	CcSEcCtD
Ifosfamide—Renal impairment—Docetaxel—head and neck cancer	0.000225	0.00198	CcSEcCtD
Ifosfamide—Myocardial infarction—Fluorouracil—head and neck cancer	0.000224	0.00197	CcSEcCtD
Ifosfamide—Neuropathy peripheral—Fluorouracil—head and neck cancer	0.000224	0.00197	CcSEcCtD
Ifosfamide—Malaise—Hydroxyurea—head and neck cancer	0.000223	0.00197	CcSEcCtD
Ifosfamide—Stomatitis—Fluorouracil—head and neck cancer	0.000222	0.00196	CcSEcCtD
Ifosfamide—Conjunctivitis—Fluorouracil—head and neck cancer	0.000222	0.00196	CcSEcCtD
Ifosfamide—Leukopenia—Hydroxyurea—head and neck cancer	0.000222	0.00196	CcSEcCtD
Ifosfamide—Cardiac failure—Docetaxel—head and neck cancer	0.000219	0.00193	CcSEcCtD
Ifosfamide—Thrombocytopenia—Vinblastine—head and neck cancer	0.000217	0.00191	CcSEcCtD
Ifosfamide—Convulsion—Hydroxyurea—head and neck cancer	0.000215	0.00189	CcSEcCtD
Ifosfamide—Gastrointestinal haemorrhage—Docetaxel—head and neck cancer	0.000214	0.00189	CcSEcCtD
Ifosfamide—Pain in extremity—Docetaxel—head and neck cancer	0.000214	0.00189	CcSEcCtD
Ifosfamide—Agranulocytosis—Fluorouracil—head and neck cancer	0.000213	0.00188	CcSEcCtD
Ifosfamide—Anorexia—Vinblastine—head and neck cancer	0.000211	0.00186	CcSEcCtD
Ifosfamide—Unspecified disorder of skin and subcutaneous tissue—Hydroxyurea—head and neck cancer	0.000209	0.00185	CcSEcCtD
Ifosfamide—Discomfort—Hydroxyurea—head and neck cancer	0.000208	0.00184	CcSEcCtD
Ifosfamide—Haemoglobin—Fluorouracil—head and neck cancer	0.000206	0.00182	CcSEcCtD
Ifosfamide—Haemorrhage—Fluorouracil—head and neck cancer	0.000205	0.00181	CcSEcCtD
Ifosfamide—Oedema—Hydroxyurea—head and neck cancer	0.000202	0.00178	CcSEcCtD
Ifosfamide—Infection—Hydroxyurea—head and neck cancer	0.000201	0.00177	CcSEcCtD
Ifosfamide—Paraesthesia—Vinblastine—head and neck cancer	0.000199	0.00176	CcSEcCtD
Ifosfamide—Nervous system disorder—Hydroxyurea—head and neck cancer	0.000198	0.00175	CcSEcCtD
Ifosfamide—Thrombocytopenia—Hydroxyurea—head and neck cancer	0.000198	0.00175	CcSEcCtD
Ifosfamide—Skin disorder—Hydroxyurea—head and neck cancer	0.000196	0.00173	CcSEcCtD
Ifosfamide—Breast disorder—Docetaxel—head and neck cancer	0.000193	0.0017	CcSEcCtD
Ifosfamide—Anorexia—Hydroxyurea—head and neck cancer	0.000193	0.0017	CcSEcCtD
Ifosfamide—Decreased appetite—Vinblastine—head and neck cancer	0.000193	0.0017	CcSEcCtD
Ifosfamide—Toxic epidermal necrolysis—Docetaxel—head and neck cancer	0.000192	0.0017	CcSEcCtD
Ifosfamide—Pain—Vinblastine—head and neck cancer	0.00019	0.00167	CcSEcCtD
Ifosfamide—Constipation—Vinblastine—head and neck cancer	0.00019	0.00167	CcSEcCtD
Ifosfamide—Arrhythmia—Fluorouracil—head and neck cancer	0.000183	0.00161	CcSEcCtD
Ifosfamide—Feeling abnormal—Vinblastine—head and neck cancer	0.000183	0.00161	CcSEcCtD
Ifosfamide—Bronchospasm—Docetaxel—head and neck cancer	0.000182	0.0016	CcSEcCtD
Ifosfamide—Gastrointestinal pain—Vinblastine—head and neck cancer	0.000181	0.0016	CcSEcCtD
Ifosfamide—Alopecia—Fluorouracil—head and neck cancer	0.000181	0.0016	CcSEcCtD
Ifosfamide—Dyspnoea—Hydroxyurea—head and neck cancer	0.00018	0.00159	CcSEcCtD
Ifosfamide—Angina pectoris—Docetaxel—head and neck cancer	0.00018	0.00159	CcSEcCtD
Ifosfamide—Somnolence—Hydroxyurea—head and neck cancer	0.00018	0.00159	CcSEcCtD
Ifosfamide—Erythema—Fluorouracil—head and neck cancer	0.000178	0.00157	CcSEcCtD
Ifosfamide—Decreased appetite—Hydroxyurea—head and neck cancer	0.000176	0.00155	CcSEcCtD
Ifosfamide—Pancytopenia—Docetaxel—head and neck cancer	0.000175	0.00155	CcSEcCtD
Ifosfamide—Abdominal pain—Vinblastine—head and neck cancer	0.000175	0.00155	CcSEcCtD
Ifosfamide—Gastrointestinal disorder—Hydroxyurea—head and neck cancer	0.000175	0.00154	CcSEcCtD
Ifosfamide—Fatigue—Hydroxyurea—head and neck cancer	0.000174	0.00154	CcSEcCtD
Ifosfamide—Pain—Hydroxyurea—head and neck cancer	0.000173	0.00153	CcSEcCtD
Ifosfamide—Constipation—Hydroxyurea—head and neck cancer	0.000173	0.00153	CcSEcCtD
Ifosfamide—Vision blurred—Fluorouracil—head and neck cancer	0.000168	0.00148	CcSEcCtD
Ifosfamide—Feeling abnormal—Hydroxyurea—head and neck cancer	0.000167	0.00147	CcSEcCtD
Ifosfamide—Pneumonia—Docetaxel—head and neck cancer	0.000166	0.00146	CcSEcCtD
Ifosfamide—Anaemia—Fluorouracil—head and neck cancer	0.000165	0.00145	CcSEcCtD
Ifosfamide—Infestation NOS—Docetaxel—head and neck cancer	0.000165	0.00145	CcSEcCtD
Ifosfamide—Infestation—Docetaxel—head and neck cancer	0.000165	0.00145	CcSEcCtD
Ifosfamide—Hypersensitivity—Vinblastine—head and neck cancer	0.000163	0.00144	CcSEcCtD
Ifosfamide—Stevens-Johnson syndrome—Docetaxel—head and neck cancer	0.000163	0.00144	CcSEcCtD
Ifosfamide—Acute coronary syndrome—Docetaxel—head and neck cancer	0.000162	0.00143	CcSEcCtD
Ifosfamide—Renal failure—Docetaxel—head and neck cancer	0.000162	0.00143	CcSEcCtD
Ifosfamide—Neuropathy peripheral—Docetaxel—head and neck cancer	0.000161	0.00142	CcSEcCtD
Ifosfamide—Myocardial infarction—Docetaxel—head and neck cancer	0.000161	0.00142	CcSEcCtD
Ifosfamide—Stomatitis—Docetaxel—head and neck cancer	0.00016	0.00142	CcSEcCtD
Ifosfamide—Conjunctivitis—Docetaxel—head and neck cancer	0.00016	0.00141	CcSEcCtD
Ifosfamide—Body temperature increased—Hydroxyurea—head and neck cancer	0.00016	0.00141	CcSEcCtD
Ifosfamide—Leukopenia—Fluorouracil—head and neck cancer	0.00016	0.00141	CcSEcCtD
Ifosfamide—Asthenia—Vinblastine—head and neck cancer	0.000159	0.0014	CcSEcCtD
Ifosfamide—Hepatobiliary disease—Docetaxel—head and neck cancer	0.000156	0.00137	CcSEcCtD
Ifosfamide—Convulsion—Fluorouracil—head and neck cancer	0.000154	0.00136	CcSEcCtD
Ifosfamide—Agranulocytosis—Docetaxel—head and neck cancer	0.000154	0.00136	CcSEcCtD
Ifosfamide—Chest pain—Fluorouracil—head and neck cancer	0.000152	0.00134	CcSEcCtD
Ifosfamide—Myalgia—Fluorouracil—head and neck cancer	0.000152	0.00134	CcSEcCtD
Ifosfamide—Diarrhoea—Vinblastine—head and neck cancer	0.000152	0.00134	CcSEcCtD
Ifosfamide—Discomfort—Fluorouracil—head and neck cancer	0.00015	0.00132	CcSEcCtD
Ifosfamide—Hypersensitivity—Hydroxyurea—head and neck cancer	0.000149	0.00131	CcSEcCtD
Ifosfamide—Haemoglobin—Docetaxel—head and neck cancer	0.000149	0.00131	CcSEcCtD
Ifosfamide—Haemorrhage—Docetaxel—head and neck cancer	0.000148	0.0013	CcSEcCtD
Ifosfamide—Hepatitis—Docetaxel—head and neck cancer	0.000148	0.0013	CcSEcCtD
Ifosfamide—Confusional state—Fluorouracil—head and neck cancer	0.000147	0.00129	CcSEcCtD
Ifosfamide—Dizziness—Vinblastine—head and neck cancer	0.000147	0.00129	CcSEcCtD
Ifosfamide—Urinary tract disorder—Docetaxel—head and neck cancer	0.000146	0.00129	CcSEcCtD
Ifosfamide—Anaphylactic shock—Fluorouracil—head and neck cancer	0.000145	0.00128	CcSEcCtD
Ifosfamide—Oedema—Fluorouracil—head and neck cancer	0.000145	0.00128	CcSEcCtD
Ifosfamide—Connective tissue disorder—Docetaxel—head and neck cancer	0.000145	0.00128	CcSEcCtD
Ifosfamide—Asthenia—Hydroxyurea—head and neck cancer	0.000145	0.00128	CcSEcCtD
Ifosfamide—Urethral disorder—Docetaxel—head and neck cancer	0.000145	0.00128	CcSEcCtD
Ifosfamide—Infection—Fluorouracil—head and neck cancer	0.000145	0.00128	CcSEcCtD
Ifosfamide—Nervous system disorder—Fluorouracil—head and neck cancer	0.000143	0.00126	CcSEcCtD
Ifosfamide—Thrombocytopenia—Fluorouracil—head and neck cancer	0.000142	0.00126	CcSEcCtD
Ifosfamide—Visual impairment—Docetaxel—head and neck cancer	0.000142	0.00126	CcSEcCtD
Ifosfamide—Vomiting—Vinblastine—head and neck cancer	0.000141	0.00124	CcSEcCtD
Ifosfamide—Erythema multiforme—Docetaxel—head and neck cancer	0.00014	0.00123	CcSEcCtD
Ifosfamide—Anorexia—Fluorouracil—head and neck cancer	0.000139	0.00122	CcSEcCtD
Ifosfamide—Diarrhoea—Hydroxyurea—head and neck cancer	0.000138	0.00122	CcSEcCtD
Ifosfamide—Eye disorder—Docetaxel—head and neck cancer	0.000138	0.00122	CcSEcCtD
Ifosfamide—Flushing—Docetaxel—head and neck cancer	0.000137	0.00121	CcSEcCtD
Ifosfamide—Cardiac disorder—Docetaxel—head and neck cancer	0.000137	0.00121	CcSEcCtD
Ifosfamide—Hypotension—Fluorouracil—head and neck cancer	0.000136	0.0012	CcSEcCtD
Ifosfamide—Angiopathy—Docetaxel—head and neck cancer	0.000134	0.00118	CcSEcCtD
Ifosfamide—Dizziness—Hydroxyurea—head and neck cancer	0.000134	0.00118	CcSEcCtD
Ifosfamide—Immune system disorder—Docetaxel—head and neck cancer	0.000134	0.00118	CcSEcCtD
Ifosfamide—Mediastinal disorder—Docetaxel—head and neck cancer	0.000133	0.00118	CcSEcCtD
Ifosfamide—Chills—Docetaxel—head and neck cancer	0.000133	0.00117	CcSEcCtD
Ifosfamide—Musculoskeletal discomfort—Fluorouracil—head and neck cancer	0.000133	0.00117	CcSEcCtD
Ifosfamide—Arrhythmia—Docetaxel—head and neck cancer	0.000132	0.00117	CcSEcCtD
Ifosfamide—Nausea—Vinblastine—head and neck cancer	0.000132	0.00116	CcSEcCtD
Ifosfamide—Paraesthesia—Fluorouracil—head and neck cancer	0.000131	0.00115	CcSEcCtD
Ifosfamide—Alopecia—Docetaxel—head and neck cancer	0.000131	0.00115	CcSEcCtD
Ifosfamide—Dyspnoea—Fluorouracil—head and neck cancer	0.00013	0.00114	CcSEcCtD
Ifosfamide—Mental disorder—Docetaxel—head and neck cancer	0.000129	0.00114	CcSEcCtD
Ifosfamide—Somnolence—Fluorouracil—head and neck cancer	0.000129	0.00114	CcSEcCtD
Ifosfamide—Malnutrition—Docetaxel—head and neck cancer	0.000129	0.00114	CcSEcCtD
Ifosfamide—Erythema—Docetaxel—head and neck cancer	0.000129	0.00114	CcSEcCtD
Ifosfamide—PTGS1—Eicosanoid Synthesis—PTGS2—head and neck cancer	0.000129	0.00813	CbGpPWpGaD
Ifosfamide—Vomiting—Hydroxyurea—head and neck cancer	0.000129	0.00113	CcSEcCtD
Ifosfamide—Rash—Hydroxyurea—head and neck cancer	0.000127	0.00112	CcSEcCtD
Ifosfamide—Dermatitis—Hydroxyurea—head and neck cancer	0.000127	0.00112	CcSEcCtD
Ifosfamide—Decreased appetite—Fluorouracil—head and neck cancer	0.000126	0.00112	CcSEcCtD
Ifosfamide—CYP2C9—Tamoxifen metabolism—CYP1A1—head and neck cancer	0.000126	0.00799	CbGpPWpGaD
Ifosfamide—Gastrointestinal disorder—Fluorouracil—head and neck cancer	0.000126	0.00111	CcSEcCtD
Ifosfamide—Pain—Fluorouracil—head and neck cancer	0.000124	0.0011	CcSEcCtD
Ifosfamide—PTGS1—Arachidonic acid metabolism—GPX1—head and neck cancer	0.000121	0.00767	CbGpPWpGaD
Ifosfamide—PTGS1—Arachidonic acid metabolism—CYP1A1—head and neck cancer	0.00012	0.0076	CbGpPWpGaD
Ifosfamide—Nausea—Hydroxyurea—head and neck cancer	0.00012	0.00106	CcSEcCtD
Ifosfamide—Feeling abnormal—Fluorouracil—head and neck cancer	0.00012	0.00106	CcSEcCtD
Ifosfamide—Anaemia—Docetaxel—head and neck cancer	0.000119	0.00105	CcSEcCtD
Ifosfamide—Urticaria—Fluorouracil—head and neck cancer	0.000116	0.00102	CcSEcCtD
Ifosfamide—Leukopenia—Docetaxel—head and neck cancer	0.000115	0.00102	CcSEcCtD
Ifosfamide—Body temperature increased—Fluorouracil—head and neck cancer	0.000115	0.00101	CcSEcCtD
Ifosfamide—Palpitations—Docetaxel—head and neck cancer	0.000114	0.001	CcSEcCtD
Ifosfamide—Cough—Docetaxel—head and neck cancer	0.000112	0.000991	CcSEcCtD
Ifosfamide—Convulsion—Docetaxel—head and neck cancer	0.000111	0.000984	CcSEcCtD
Ifosfamide—Hypertension—Docetaxel—head and neck cancer	0.000111	0.00098	CcSEcCtD
Ifosfamide—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—RARB—head and neck cancer	0.000111	0.007	CbGpPWpGaD
Ifosfamide—Chest pain—Docetaxel—head and neck cancer	0.00011	0.000967	CcSEcCtD
Ifosfamide—Arthralgia—Docetaxel—head and neck cancer	0.00011	0.000967	CcSEcCtD
Ifosfamide—Myalgia—Docetaxel—head and neck cancer	0.00011	0.000967	CcSEcCtD
Ifosfamide—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—head and neck cancer	0.000109	0.00096	CcSEcCtD
Ifosfamide—PTGS1—Prostaglandin Synthesis and Regulation—PTGS2—head and neck cancer	0.000108	0.0068	CbGpPWpGaD
Ifosfamide—Hypersensitivity—Fluorouracil—head and neck cancer	0.000107	0.000946	CcSEcCtD
Ifosfamide—CYP3A7—Cytochrome P450 - arranged by substrate type—CYP1A1—head and neck cancer	0.000107	0.00677	CbGpPWpGaD
Ifosfamide—CYP2C19—Melatonin metabolism and effects—CYP1A1—head and neck cancer	0.000107	0.00677	CbGpPWpGaD
Ifosfamide—Confusional state—Docetaxel—head and neck cancer	0.000106	0.000934	CcSEcCtD
Ifosfamide—CYP3A7—Oxidation by Cytochrome P450—CYP1A1—head and neck cancer	0.000106	0.00668	CbGpPWpGaD
Ifosfamide—Anaphylactic shock—Docetaxel—head and neck cancer	0.000105	0.000927	CcSEcCtD
Ifosfamide—Oedema—Docetaxel—head and neck cancer	0.000105	0.000927	CcSEcCtD
Ifosfamide—Infection—Docetaxel—head and neck cancer	0.000104	0.000921	CcSEcCtD
Ifosfamide—CYP3A4—Fatty Acid Omega Oxidation—CYP1A1—head and neck cancer	0.000104	0.00655	CbGpPWpGaD
Ifosfamide—Nervous system disorder—Docetaxel—head and neck cancer	0.000103	0.000909	CcSEcCtD
Ifosfamide—Pruritus—Fluorouracil—head and neck cancer	0.000103	0.000908	CcSEcCtD
Ifosfamide—Thrombocytopenia—Docetaxel—head and neck cancer	0.000103	0.000907	CcSEcCtD
Ifosfamide—Skin disorder—Docetaxel—head and neck cancer	0.000102	0.0009	CcSEcCtD
Ifosfamide—Anorexia—Docetaxel—head and neck cancer	0.0001	0.000883	CcSEcCtD
Ifosfamide—Diarrhoea—Fluorouracil—head and neck cancer	9.95e-05	0.000878	CcSEcCtD
Ifosfamide—CYP3A4—Estrogen metabolism—GSTM1—head and neck cancer	9.95e-05	0.00629	CbGpPWpGaD
Ifosfamide—CYP3A7—Biological oxidations—NAT2—head and neck cancer	9.86e-05	0.00623	CbGpPWpGaD
Ifosfamide—CYP2A6—Cytochrome P450 - arranged by substrate type—CYP1A1—head and neck cancer	9.82e-05	0.00621	CbGpPWpGaD
Ifosfamide—Hypotension—Docetaxel—head and neck cancer	9.81e-05	0.000866	CcSEcCtD
Ifosfamide—CYP3A7—Metapathway biotransformation—NAT2—head and neck cancer	9.72e-05	0.00614	CbGpPWpGaD
Ifosfamide—CYP2A6—Oxidation by Cytochrome P450—CYP1A1—head and neck cancer	9.69e-05	0.00613	CbGpPWpGaD
Ifosfamide—Dizziness—Fluorouracil—head and neck cancer	9.62e-05	0.000849	CcSEcCtD
Ifosfamide—Musculoskeletal discomfort—Docetaxel—head and neck cancer	9.57e-05	0.000844	CcSEcCtD
Ifosfamide—PTGS1—Biological oxidations—NAT2—head and neck cancer	9.55e-05	0.00604	CbGpPWpGaD
Ifosfamide—CYP3A4—Estrogen metabolism—CYP1A1—head and neck cancer	9.44e-05	0.00596	CbGpPWpGaD
Ifosfamide—Paraesthesia—Docetaxel—head and neck cancer	9.43e-05	0.000832	CcSEcCtD
Ifosfamide—Dyspnoea—Docetaxel—head and neck cancer	9.36e-05	0.000826	CcSEcCtD
Ifosfamide—Somnolence—Docetaxel—head and neck cancer	9.34e-05	0.000824	CcSEcCtD
Ifosfamide—Vomiting—Fluorouracil—head and neck cancer	9.25e-05	0.000816	CcSEcCtD
Ifosfamide—Rash—Fluorouracil—head and neck cancer	9.17e-05	0.000809	CcSEcCtD
Ifosfamide—Dermatitis—Fluorouracil—head and neck cancer	9.17e-05	0.000809	CcSEcCtD
Ifosfamide—Decreased appetite—Docetaxel—head and neck cancer	9.13e-05	0.000805	CcSEcCtD
Ifosfamide—Gastrointestinal disorder—Docetaxel—head and neck cancer	9.07e-05	0.0008	CcSEcCtD
Ifosfamide—Fatigue—Docetaxel—head and neck cancer	9.05e-05	0.000799	CcSEcCtD
Ifosfamide—CYP2A6—Biological oxidations—NAT2—head and neck cancer	9.03e-05	0.00571	CbGpPWpGaD
Ifosfamide—Constipation—Docetaxel—head and neck cancer	8.98e-05	0.000792	CcSEcCtD
Ifosfamide—Pain—Docetaxel—head and neck cancer	8.98e-05	0.000792	CcSEcCtD
Ifosfamide—CYP2A6—NRF2 pathway—TGFA—head and neck cancer	8.76e-05	0.00554	CbGpPWpGaD
Ifosfamide—CYP3A7—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	8.69e-05	0.00549	CbGpPWpGaD
Ifosfamide—CYP3A4—Xenobiotics—CYP1A1—head and neck cancer	8.67e-05	0.00548	CbGpPWpGaD
Ifosfamide—Feeling abnormal—Docetaxel—head and neck cancer	8.65e-05	0.000764	CcSEcCtD
Ifosfamide—Nausea—Fluorouracil—head and neck cancer	8.64e-05	0.000763	CcSEcCtD
Ifosfamide—Gastrointestinal pain—Docetaxel—head and neck cancer	8.59e-05	0.000758	CcSEcCtD
Ifosfamide—PTGS1—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	8.42e-05	0.00532	CbGpPWpGaD
Ifosfamide—CYP3A4—Tamoxifen metabolism—CYP1A1—head and neck cancer	8.34e-05	0.00527	CbGpPWpGaD
Ifosfamide—Abdominal pain—Docetaxel—head and neck cancer	8.3e-05	0.000732	CcSEcCtD
Ifosfamide—Body temperature increased—Docetaxel—head and neck cancer	8.3e-05	0.000732	CcSEcCtD
Ifosfamide—PTGS1—Selenium Micronutrient Network—SOD2—head and neck cancer	8.1e-05	0.00512	CbGpPWpGaD
Ifosfamide—CYP2A6—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	7.96e-05	0.00503	CbGpPWpGaD
Ifosfamide—CYP2B6—Cytochrome P450 - arranged by substrate type—CYP1A1—head and neck cancer	7.93e-05	0.00501	CbGpPWpGaD
Ifosfamide—CYP2C8—Arachidonic acid metabolism—GPX1—head and neck cancer	7.84e-05	0.00496	CbGpPWpGaD
Ifosfamide—CYP2B6—Oxidation by Cytochrome P450—CYP1A1—head and neck cancer	7.82e-05	0.00494	CbGpPWpGaD
Ifosfamide—CYP2C8—Arachidonic acid metabolism—CYP1A1—head and neck cancer	7.76e-05	0.00491	CbGpPWpGaD
Ifosfamide—CYP3A5—Cytochrome P450 - arranged by substrate type—CYP1A1—head and neck cancer	7.75e-05	0.0049	CbGpPWpGaD
Ifosfamide—Hypersensitivity—Docetaxel—head and neck cancer	7.74e-05	0.000683	CcSEcCtD
Ifosfamide—PTGS1—Selenium Micronutrient Network—GPX1—head and neck cancer	7.72e-05	0.00488	CbGpPWpGaD
Ifosfamide—CYP3A5—Oxidation by Cytochrome P450—CYP1A1—head and neck cancer	7.64e-05	0.00483	CbGpPWpGaD
Ifosfamide—Asthenia—Docetaxel—head and neck cancer	7.53e-05	0.000665	CcSEcCtD
Ifosfamide—Pruritus—Docetaxel—head and neck cancer	7.43e-05	0.000656	CcSEcCtD
Ifosfamide—CYP2C18—Biological oxidations—GSTM1—head and neck cancer	7.32e-05	0.00463	CbGpPWpGaD
Ifosfamide—CYP2B6—Biological oxidations—NAT2—head and neck cancer	7.29e-05	0.00461	CbGpPWpGaD
Ifosfamide—CYP2C18—Metapathway biotransformation—GSTM1—head and neck cancer	7.22e-05	0.00456	CbGpPWpGaD
Ifosfamide—CYP2B6—Metapathway biotransformation—NAT2—head and neck cancer	7.19e-05	0.00454	CbGpPWpGaD
Ifosfamide—Diarrhoea—Docetaxel—head and neck cancer	7.19e-05	0.000634	CcSEcCtD
Ifosfamide—PTGS1—Arachidonic acid metabolism—PTGS2—head and neck cancer	7.15e-05	0.00452	CbGpPWpGaD
Ifosfamide—CYP3A5—Biological oxidations—NAT2—head and neck cancer	7.12e-05	0.0045	CbGpPWpGaD
Ifosfamide—CYP3A5—Metapathway biotransformation—NAT2—head and neck cancer	7.03e-05	0.00444	CbGpPWpGaD
Ifosfamide—CYP2C19—Arachidonic acid metabolism—GPX1—head and neck cancer	7e-05	0.00442	CbGpPWpGaD
Ifosfamide—Dizziness—Docetaxel—head and neck cancer	6.94e-05	0.000613	CcSEcCtD
Ifosfamide—CYP2C18—Biological oxidations—CYP1A1—head and neck cancer	6.94e-05	0.00439	CbGpPWpGaD
Ifosfamide—CYP2C19—Arachidonic acid metabolism—CYP1A1—head and neck cancer	6.93e-05	0.00438	CbGpPWpGaD
Ifosfamide—CYP2C18—Metapathway biotransformation—CYP1A1—head and neck cancer	6.85e-05	0.00433	CbGpPWpGaD
Ifosfamide—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP1A1—head and neck cancer	6.71e-05	0.00424	CbGpPWpGaD
Ifosfamide—Vomiting—Docetaxel—head and neck cancer	6.68e-05	0.000589	CcSEcCtD
Ifosfamide—CYP2C8—Oxidation by Cytochrome P450—CYP1A1—head and neck cancer	6.62e-05	0.00419	CbGpPWpGaD
Ifosfamide—Rash—Docetaxel—head and neck cancer	6.62e-05	0.000584	CcSEcCtD
Ifosfamide—Dermatitis—Docetaxel—head and neck cancer	6.62e-05	0.000584	CcSEcCtD
Ifosfamide—CYP2B6—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	6.42e-05	0.00406	CbGpPWpGaD
Ifosfamide—CYP2C9—Arachidonic acid metabolism—GPX1—head and neck cancer	6.38e-05	0.00403	CbGpPWpGaD
Ifosfamide—CYP2C9—Arachidonic acid metabolism—CYP1A1—head and neck cancer	6.32e-05	0.00399	CbGpPWpGaD
Ifosfamide—CYP3A5—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	6.28e-05	0.00397	CbGpPWpGaD
Ifosfamide—Nausea—Docetaxel—head and neck cancer	6.24e-05	0.00055	CcSEcCtD
Ifosfamide—CYP2C8—Biological oxidations—NAT2—head and neck cancer	6.17e-05	0.0039	CbGpPWpGaD
Ifosfamide—CYP2C18—Metabolism—UROD—head and neck cancer	6.11e-05	0.00386	CbGpPWpGaD
Ifosfamide—CYP2C8—Metapathway biotransformation—NAT2—head and neck cancer	6.09e-05	0.00385	CbGpPWpGaD
Ifosfamide—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP1A1—head and neck cancer	5.99e-05	0.00379	CbGpPWpGaD
Ifosfamide—CYP2C19—Oxidation by Cytochrome P450—CYP1A1—head and neck cancer	5.91e-05	0.00374	CbGpPWpGaD
Ifosfamide—CYP2A6—Fluoropyrimidine Activity—TP53—head and neck cancer	5.61e-05	0.00355	CbGpPWpGaD
Ifosfamide—CYP2C19—Biological oxidations—NAT2—head and neck cancer	5.51e-05	0.00348	CbGpPWpGaD
Ifosfamide—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP1A1—head and neck cancer	5.46e-05	0.00345	CbGpPWpGaD
Ifosfamide—CYP2C8—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	5.44e-05	0.00344	CbGpPWpGaD
Ifosfamide—CYP2C19—Metapathway biotransformation—NAT2—head and neck cancer	5.43e-05	0.00343	CbGpPWpGaD
Ifosfamide—CYP2C9—Oxidation by Cytochrome P450—CYP1A1—head and neck cancer	5.39e-05	0.00341	CbGpPWpGaD
Ifosfamide—CYP2A6—NRF2 pathway—GSTM1—head and neck cancer	5.09e-05	0.00322	CbGpPWpGaD
Ifosfamide—CYP2C9—Biological oxidations—NAT2—head and neck cancer	5.02e-05	0.00317	CbGpPWpGaD
Ifosfamide—CYP2C9—Metapathway biotransformation—NAT2—head and neck cancer	4.95e-05	0.00313	CbGpPWpGaD
Ifosfamide—CYP3A7—Biological oxidations—GSTM1—head and neck cancer	4.87e-05	0.00308	CbGpPWpGaD
Ifosfamide—CYP2C19—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	4.86e-05	0.00307	CbGpPWpGaD
Ifosfamide—CYP3A7—Metapathway biotransformation—GSTM1—head and neck cancer	4.8e-05	0.00303	CbGpPWpGaD
Ifosfamide—PTGS1—Biological oxidations—GSTM1—head and neck cancer	4.72e-05	0.00298	CbGpPWpGaD
Ifosfamide—CYP2C8—Arachidonic acid metabolism—PTGS2—head and neck cancer	4.62e-05	0.00292	CbGpPWpGaD
Ifosfamide—CYP3A7—Biological oxidations—CYP1A1—head and neck cancer	4.61e-05	0.00292	CbGpPWpGaD
Ifosfamide—CYP3A7—Metapathway biotransformation—CYP1A1—head and neck cancer	4.55e-05	0.00288	CbGpPWpGaD
Ifosfamide—PTGS1—Selenium Micronutrient Network—PTGS2—head and neck cancer	4.55e-05	0.00287	CbGpPWpGaD
Ifosfamide—PTGS1—Biological oxidations—CYP1A1—head and neck cancer	4.47e-05	0.00283	CbGpPWpGaD
Ifosfamide—CYP2A6—Biological oxidations—GSTM1—head and neck cancer	4.46e-05	0.00282	CbGpPWpGaD
Ifosfamide—CYP3A4—Tryptophan metabolism—CYP1A1—head and neck cancer	4.45e-05	0.00282	CbGpPWpGaD
Ifosfamide—CYP2C9—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	4.43e-05	0.0028	CbGpPWpGaD
Ifosfamide—CYP2A6—Biological oxidations—CYP1A1—head and neck cancer	4.23e-05	0.00267	CbGpPWpGaD
Ifosfamide—CYP2C19—Arachidonic acid metabolism—PTGS2—head and neck cancer	4.12e-05	0.0026	CbGpPWpGaD
Ifosfamide—CYP3A7—Metabolism—UROD—head and neck cancer	4.06e-05	0.00257	CbGpPWpGaD
Ifosfamide—PTGS1—Metabolism—UROD—head and neck cancer	3.93e-05	0.00249	CbGpPWpGaD
Ifosfamide—CYP2C9—Arachidonic acid metabolism—PTGS2—head and neck cancer	3.76e-05	0.00238	CbGpPWpGaD
Ifosfamide—CYP2A6—Metabolism—UROD—head and neck cancer	3.72e-05	0.00235	CbGpPWpGaD
Ifosfamide—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—head and neck cancer	3.6e-05	0.00228	CbGpPWpGaD
Ifosfamide—CYP2B6—Biological oxidations—GSTM1—head and neck cancer	3.6e-05	0.00228	CbGpPWpGaD
Ifosfamide—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—head and neck cancer	3.55e-05	0.00225	CbGpPWpGaD
Ifosfamide—CYP2B6—Metapathway biotransformation—GSTM1—head and neck cancer	3.55e-05	0.00224	CbGpPWpGaD
Ifosfamide—CYP3A5—Biological oxidations—GSTM1—head and neck cancer	3.52e-05	0.00222	CbGpPWpGaD
Ifosfamide—CYP3A5—Metapathway biotransformation—GSTM1—head and neck cancer	3.47e-05	0.00219	CbGpPWpGaD
Ifosfamide—CYP2B6—Biological oxidations—CYP1A1—head and neck cancer	3.41e-05	0.00216	CbGpPWpGaD
Ifosfamide—CYP2B6—Metapathway biotransformation—CYP1A1—head and neck cancer	3.37e-05	0.00213	CbGpPWpGaD
Ifosfamide—CYP3A5—Biological oxidations—CYP1A1—head and neck cancer	3.34e-05	0.00211	CbGpPWpGaD
Ifosfamide—CYP3A4—Biological oxidations—NAT2—head and neck cancer	3.31e-05	0.00209	CbGpPWpGaD
Ifosfamide—CYP3A5—Metapathway biotransformation—CYP1A1—head and neck cancer	3.29e-05	0.00208	CbGpPWpGaD
Ifosfamide—CYP3A4—Metapathway biotransformation—NAT2—head and neck cancer	3.27e-05	0.00206	CbGpPWpGaD
Ifosfamide—PTGS1—Metabolism of lipids and lipoproteins—YAP1—head and neck cancer	3.05e-05	0.00193	CbGpPWpGaD
Ifosfamide—CYP2C8—Biological oxidations—GSTM1—head and neck cancer	3.05e-05	0.00193	CbGpPWpGaD
Ifosfamide—CYP2C8—Metapathway biotransformation—GSTM1—head and neck cancer	3.01e-05	0.0019	CbGpPWpGaD
Ifosfamide—CYP2B6—Metabolism—UROD—head and neck cancer	3e-05	0.0019	CbGpPWpGaD
Ifosfamide—CYP3A5—Metabolism—UROD—head and neck cancer	2.93e-05	0.00185	CbGpPWpGaD
Ifosfamide—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	2.92e-05	0.00185	CbGpPWpGaD
Ifosfamide—CYP2C8—Biological oxidations—CYP1A1—head and neck cancer	2.89e-05	0.00183	CbGpPWpGaD
Ifosfamide—CYP2C8—Metapathway biotransformation—CYP1A1—head and neck cancer	2.85e-05	0.0018	CbGpPWpGaD
Ifosfamide—CYP2C19—Biological oxidations—GSTM1—head and neck cancer	2.72e-05	0.00172	CbGpPWpGaD
Ifosfamide—CYP2C19—Metapathway biotransformation—GSTM1—head and neck cancer	2.68e-05	0.0017	CbGpPWpGaD
Ifosfamide—CYP2C19—Biological oxidations—CYP1A1—head and neck cancer	2.58e-05	0.00163	CbGpPWpGaD
Ifosfamide—CYP2C19—Metapathway biotransformation—CYP1A1—head and neck cancer	2.54e-05	0.00161	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism—UROD—head and neck cancer	2.54e-05	0.00161	CbGpPWpGaD
Ifosfamide—CYP2C18—Metabolism—NAT2—head and neck cancer	2.54e-05	0.0016	CbGpPWpGaD
Ifosfamide—CYP2C9—Biological oxidations—GSTM1—head and neck cancer	2.48e-05	0.00157	CbGpPWpGaD
Ifosfamide—CYP2C9—Metapathway biotransformation—GSTM1—head and neck cancer	2.45e-05	0.00155	CbGpPWpGaD
Ifosfamide—CYP2C9—Biological oxidations—CYP1A1—head and neck cancer	2.35e-05	0.00149	CbGpPWpGaD
Ifosfamide—CYP2C9—Metapathway biotransformation—CYP1A1—head and neck cancer	2.32e-05	0.00147	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism—UROD—head and neck cancer	2.27e-05	0.00143	CbGpPWpGaD
Ifosfamide—CYP2C18—Metabolism—DPYD—head and neck cancer	2.22e-05	0.00141	CbGpPWpGaD
Ifosfamide—CYP2C18—Metabolism—YAP1—head and neck cancer	2.11e-05	0.00133	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism—UROD—head and neck cancer	2.07e-05	0.00131	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism of lipids and lipoproteins—YAP1—head and neck cancer	1.97e-05	0.00125	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism of lipids and lipoproteins—YAP1—head and neck cancer	1.76e-05	0.00111	CbGpPWpGaD
Ifosfamide—PTGS1—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	1.74e-05	0.0011	CbGpPWpGaD
Ifosfamide—PTGS1—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	1.72e-05	0.00109	CbGpPWpGaD
Ifosfamide—CYP3A7—Metabolism—NAT2—head and neck cancer	1.69e-05	0.00107	CbGpPWpGaD
Ifosfamide—CYP3A4—Biological oxidations—GSTM1—head and neck cancer	1.64e-05	0.00103	CbGpPWpGaD
Ifosfamide—PTGS1—Metabolism—NAT2—head and neck cancer	1.63e-05	0.00103	CbGpPWpGaD
Ifosfamide—CYP3A4—Metapathway biotransformation—GSTM1—head and neck cancer	1.61e-05	0.00102	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism of lipids and lipoproteins—YAP1—head and neck cancer	1.6e-05	0.00101	CbGpPWpGaD
Ifosfamide—CYP3A4—Biological oxidations—CYP1A1—head and neck cancer	1.55e-05	0.00098	CbGpPWpGaD
Ifosfamide—CYP2A6—Metabolism—NAT2—head and neck cancer	1.54e-05	0.000977	CbGpPWpGaD
Ifosfamide—CYP3A4—Metapathway biotransformation—CYP1A1—head and neck cancer	1.53e-05	0.000967	CbGpPWpGaD
Ifosfamide—CYP3A7—Metabolism—DPYD—head and neck cancer	1.48e-05	0.000934	CbGpPWpGaD
Ifosfamide—PTGS1—Metabolism—DPYD—head and neck cancer	1.43e-05	0.000906	CbGpPWpGaD
Ifosfamide—CYP3A7—Metabolism—YAP1—head and neck cancer	1.4e-05	0.000887	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—UROD—head and neck cancer	1.36e-05	0.000862	CbGpPWpGaD
Ifosfamide—PTGS1—Metabolism—YAP1—head and neck cancer	1.36e-05	0.000859	CbGpPWpGaD
Ifosfamide—CYP2A6—Metabolism—DPYD—head and neck cancer	1.35e-05	0.000856	CbGpPWpGaD
Ifosfamide—CYP2A6—Metabolism—YAP1—head and neck cancer	1.29e-05	0.000813	CbGpPWpGaD
Ifosfamide—CYP2C18—Metabolism—TYMS—head and neck cancer	1.27e-05	0.000801	CbGpPWpGaD
Ifosfamide—CYP2C18—Metabolism—GSTM1—head and neck cancer	1.25e-05	0.000792	CbGpPWpGaD
Ifosfamide—CYP2B6—Metabolism—NAT2—head and neck cancer	1.25e-05	0.000788	CbGpPWpGaD
Ifosfamide—CYP3A5—Metabolism—NAT2—head and neck cancer	1.22e-05	0.00077	CbGpPWpGaD
Ifosfamide—CYP2C18—Metabolism—GPX1—head and neck cancer	1.2e-05	0.000758	CbGpPWpGaD
Ifosfamide—CYP2C18—Metabolism—CYP1A1—head and neck cancer	1.19e-05	0.00075	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	1.12e-05	0.000708	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	1.11e-05	0.000701	CbGpPWpGaD
Ifosfamide—CYP2B6—Metabolism—DPYD—head and neck cancer	1.09e-05	0.000691	CbGpPWpGaD
Ifosfamide—CYP3A5—Metabolism—DPYD—head and neck cancer	1.07e-05	0.000675	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism—NAT2—head and neck cancer	1.06e-05	0.000667	CbGpPWpGaD
Ifosfamide—CYP2B6—Metabolism—YAP1—head and neck cancer	1.04e-05	0.000656	CbGpPWpGaD
Ifosfamide—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	1.02e-05	0.000646	CbGpPWpGaD
Ifosfamide—CYP3A5—Metabolism—YAP1—head and neck cancer	1.01e-05	0.000641	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	1e-05	0.000632	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	9.9e-06	0.000626	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism—NAT2—head and neck cancer	9.42e-06	0.000595	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism—DPYD—head and neck cancer	9.25e-06	0.000585	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	9.12e-06	0.000577	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	9.03e-06	0.000571	CbGpPWpGaD
Ifosfamide—PTGS1—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	8.91e-06	0.000563	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism—YAP1—head and neck cancer	8.78e-06	0.000555	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism—NAT2—head and neck cancer	8.59e-06	0.000543	CbGpPWpGaD
Ifosfamide—CYP3A7—Metabolism—TYMS—head and neck cancer	8.42e-06	0.000532	CbGpPWpGaD
Ifosfamide—CYP3A7—Metabolism—GSTM1—head and neck cancer	8.32e-06	0.000526	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism—DPYD—head and neck cancer	8.26e-06	0.000522	CbGpPWpGaD
Ifosfamide—PTGS1—Metabolism—TYMS—head and neck cancer	8.16e-06	0.000516	CbGpPWpGaD
Ifosfamide—PTGS1—Metabolism—GSTM1—head and neck cancer	8.07e-06	0.00051	CbGpPWpGaD
Ifosfamide—CYP3A7—Metabolism—GPX1—head and neck cancer	7.97e-06	0.000504	CbGpPWpGaD
Ifosfamide—CYP3A7—Metabolism—CYP1A1—head and neck cancer	7.89e-06	0.000499	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism—YAP1—head and neck cancer	7.84e-06	0.000495	CbGpPWpGaD
Ifosfamide—PTGS1—Metabolism—GPX1—head and neck cancer	7.73e-06	0.000488	CbGpPWpGaD
Ifosfamide—CYP2A6—Metabolism—TYMS—head and neck cancer	7.72e-06	0.000488	CbGpPWpGaD
Ifosfamide—PTGS1—Metabolism—CYP1A1—head and neck cancer	7.65e-06	0.000484	CbGpPWpGaD
Ifosfamide—CYP2A6—Metabolism—GSTM1—head and neck cancer	7.63e-06	0.000482	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism—DPYD—head and neck cancer	7.53e-06	0.000476	CbGpPWpGaD
Ifosfamide—CYP2A6—Metabolism—GPX1—head and neck cancer	7.31e-06	0.000462	CbGpPWpGaD
Ifosfamide—CYP2A6—Metabolism—CYP1A1—head and neck cancer	7.23e-06	0.000457	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism—YAP1—head and neck cancer	7.15e-06	0.000452	CbGpPWpGaD
Ifosfamide—CYP2C18—Metabolism—PTGS2—head and neck cancer	7.06e-06	0.000446	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	6.6e-06	0.000417	CbGpPWpGaD
Ifosfamide—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	6.28e-06	0.000397	CbGpPWpGaD
Ifosfamide—CYP2B6—Metabolism—TYMS—head and neck cancer	6.23e-06	0.000394	CbGpPWpGaD
Ifosfamide—CYP2C18—Metabolism—PTEN—head and neck cancer	6.16e-06	0.000389	CbGpPWpGaD
Ifosfamide—CYP2B6—Metabolism—GSTM1—head and neck cancer	6.16e-06	0.000389	CbGpPWpGaD
Ifosfamide—CYP3A5—Metabolism—TYMS—head and neck cancer	6.09e-06	0.000385	CbGpPWpGaD
Ifosfamide—CYP3A5—Metabolism—GSTM1—head and neck cancer	6.02e-06	0.00038	CbGpPWpGaD
Ifosfamide—CYP2B6—Metabolism—GPX1—head and neck cancer	5.9e-06	0.000373	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	5.89e-06	0.000372	CbGpPWpGaD
Ifosfamide—CYP2B6—Metabolism—CYP1A1—head and neck cancer	5.84e-06	0.000369	CbGpPWpGaD
Ifosfamide—CYP3A5—Metabolism—GPX1—head and neck cancer	5.76e-06	0.000364	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	5.75e-06	0.000364	CbGpPWpGaD
Ifosfamide—CYP3A5—Metabolism—CYP1A1—head and neck cancer	5.7e-06	0.000361	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—NAT2—head and neck cancer	5.66e-06	0.000358	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	5.37e-06	0.000339	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism—TYMS—head and neck cancer	5.27e-06	0.000333	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism—GSTM1—head and neck cancer	5.21e-06	0.000329	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	5.14e-06	0.000325	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism—GPX1—head and neck cancer	4.99e-06	0.000316	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—DPYD—head and neck cancer	4.97e-06	0.000314	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism—CYP1A1—head and neck cancer	4.94e-06	0.000312	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—YAP1—head and neck cancer	4.71e-06	0.000298	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism—TYMS—head and neck cancer	4.71e-06	0.000298	CbGpPWpGaD
Ifosfamide—CYP3A7—Metabolism—PTGS2—head and neck cancer	4.69e-06	0.000297	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	4.68e-06	0.000296	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism—GSTM1—head and neck cancer	4.65e-06	0.000294	CbGpPWpGaD
Ifosfamide—PTGS1—Metabolism—PTGS2—head and neck cancer	4.55e-06	0.000288	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism—GPX1—head and neck cancer	4.46e-06	0.000282	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism—CYP1A1—head and neck cancer	4.41e-06	0.000279	CbGpPWpGaD
Ifosfamide—CYP2C18—Metabolism—PIK3CA—head and neck cancer	4.34e-06	0.000275	CbGpPWpGaD
Ifosfamide—CYP2A6—Metabolism—PTGS2—head and neck cancer	4.3e-06	0.000272	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism—TYMS—head and neck cancer	4.29e-06	0.000271	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism—GSTM1—head and neck cancer	4.24e-06	0.000268	CbGpPWpGaD
Ifosfamide—CYP3A7—Metabolism—PTEN—head and neck cancer	4.09e-06	0.000259	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism—GPX1—head and neck cancer	4.06e-06	0.000257	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	4.06e-06	0.000257	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism—CYP1A1—head and neck cancer	4.02e-06	0.000254	CbGpPWpGaD
Ifosfamide—PTGS1—Metabolism—PTEN—head and neck cancer	3.97e-06	0.000251	CbGpPWpGaD
Ifosfamide—CYP2A6—Metabolism—PTEN—head and neck cancer	3.75e-06	0.000237	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	3.62e-06	0.000229	CbGpPWpGaD
Ifosfamide—CYP2C18—Metabolism—AKT1—head and neck cancer	3.55e-06	0.000224	CbGpPWpGaD
Ifosfamide—CYP2B6—Metabolism—PTGS2—head and neck cancer	3.47e-06	0.000219	CbGpPWpGaD
Ifosfamide—CYP3A5—Metabolism—PTGS2—head and neck cancer	3.39e-06	0.000214	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	3.3e-06	0.000209	CbGpPWpGaD
Ifosfamide—CYP2B6—Metabolism—PTEN—head and neck cancer	3.03e-06	0.000191	CbGpPWpGaD
Ifosfamide—CYP3A5—Metabolism—PTEN—head and neck cancer	2.96e-06	0.000187	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism—PTGS2—head and neck cancer	2.94e-06	0.000186	CbGpPWpGaD
Ifosfamide—CYP3A7—Metabolism—PIK3CA—head and neck cancer	2.89e-06	0.000183	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—TYMS—head and neck cancer	2.83e-06	0.000179	CbGpPWpGaD
Ifosfamide—PTGS1—Metabolism—PIK3CA—head and neck cancer	2.8e-06	0.000177	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—GSTM1—head and neck cancer	2.8e-06	0.000177	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—GPX1—head and neck cancer	2.68e-06	0.000169	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—CYP1A1—head and neck cancer	2.65e-06	0.000168	CbGpPWpGaD
Ifosfamide—CYP2A6—Metabolism—PIK3CA—head and neck cancer	2.65e-06	0.000167	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism—PTGS2—head and neck cancer	2.62e-06	0.000166	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism—PTEN—head and neck cancer	2.56e-06	0.000162	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism—PTGS2—head and neck cancer	2.39e-06	0.000151	CbGpPWpGaD
Ifosfamide—CYP3A7—Metabolism—AKT1—head and neck cancer	2.36e-06	0.000149	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism—PTEN—head and neck cancer	2.29e-06	0.000145	CbGpPWpGaD
Ifosfamide—PTGS1—Metabolism—AKT1—head and neck cancer	2.29e-06	0.000145	CbGpPWpGaD
Ifosfamide—CYP2A6—Metabolism—AKT1—head and neck cancer	2.16e-06	0.000137	CbGpPWpGaD
Ifosfamide—CYP2B6—Metabolism—PIK3CA—head and neck cancer	2.14e-06	0.000135	CbGpPWpGaD
Ifosfamide—CYP3A5—Metabolism—PIK3CA—head and neck cancer	2.09e-06	0.000132	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism—PTEN—head and neck cancer	2.09e-06	0.000132	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism—PIK3CA—head and neck cancer	1.81e-06	0.000114	CbGpPWpGaD
Ifosfamide—CYP2B6—Metabolism—AKT1—head and neck cancer	1.74e-06	0.00011	CbGpPWpGaD
Ifosfamide—CYP3A5—Metabolism—AKT1—head and neck cancer	1.71e-06	0.000108	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism—PIK3CA—head and neck cancer	1.61e-06	0.000102	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—PTGS2—head and neck cancer	1.58e-06	9.97e-05	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism—AKT1—head and neck cancer	1.48e-06	9.34e-05	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism—PIK3CA—head and neck cancer	1.47e-06	9.3e-05	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—PTEN—head and neck cancer	1.38e-06	8.69e-05	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism—AKT1—head and neck cancer	1.32e-06	8.33e-05	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism—AKT1—head and neck cancer	1.2e-06	7.6e-05	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—PIK3CA—head and neck cancer	9.7e-07	6.13e-05	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—AKT1—head and neck cancer	7.93e-07	5.01e-05	CbGpPWpGaD
